US 8940871
Engineered anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting
granted A61KA61K2039/505A61K51/1072
Quick answer
US patent 8940871 (Engineered anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting) held by The Regents of the University of California expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61K51/1072, A61K51/1087, A61P